Subscribe

Get latest conversations to your inbox

If you're enjoying this conversation, please subscribe to stay tuned for upcoming conversations.

Joseph Barsuglia: Is 5-MeO-DMT the Future of Psychedelic Medicine?

February 26, 2021

5-MeO-DMT could be the future of psychedelic medicine, but as Dr. Joseph Barsuglia explains, this would require a complete redesign of our current model of care.

What if you could have a more potent mystical experience than psilocybin in a quarter of the time? 5-MeO-DMT could be the future of psychedelic medicine, but as Dr. Joseph Barsuglia explains, this would require a complete redesign of our current model of care.

On the show, we discuss the nature of mystical experiences as well as our current understanding of the science of 5-MeO-DMT. Joseph reveals some of the drug development companies interested in medicalization as well as his concerns about this process. We finish with the environmental considerations for the bufo alvarious toad and lessons this medicine has for the psychedelic movement.

Joseph is a PhD neuropsychologist and the former Director of Clinical Assessment and Research at Crossroads Treatment Center which developed a protocol following ibogaine with 5-MeO-DMT. Trained with MAPS and initiated in the Bwiti tradition in Gabon, Joseph advises on psychedelic medicine and alternative healthcare.

Show notes

Links

Timestamps

  • :05 - The protocol of ibogaine + 5-MeO-DMT at Crossroads Treatment Center
  • :13 - The nature of mystical experiences
  • :20 - The science of 5-MeO-DMT
  • :24 - Specific drug development companies working with 5-MeO
  • :33 - Concerns about the medicalization of 5-MeO-DMT
  • :38 - The Conclave, a group of anonymous facilitators offer best practices and integration guides for 5-MeO online
  • :46 - Environmental concerns for bufo alvarious
  • :57 - Lessons from 5-MeO-DMT for the psychedelic movement generally
LinkedIn pink iconInstagram pink iconFacebook pink iconTwiter pink iconYoutube pink icon

About Maya’s Podcast

A conversation series with leaders in the psychedelic community. Designed in service of therapists, healers, retreat leaders, and passionate enthusiasts

View all episodes

Other podcasts you may also like

June 10, 2022

Talia Eisenberg (Beond): How Ibogaine Gets to the Root of Trauma

The West African psychedelic iboga (and its extraction ibogaine) continues to show an impressive ability to heal addiction and trauma.

Listen to Podcast
May 5, 2022

Adele Lafrance: Healing Eating Disorders with Psychedelics

The promising impact that ayahuasca, MDMA, ketamine, and psilocybin can have on a person who is struggling to heal from disordered eating.

Listen to Podcast
April 5, 2022

Laura Northrup (Inside Eyes): Psychedelics and Sexual Violence Part 2

We live in a global epidemic of sexual violence and spaces for psychedelic healing are not only not exempt, but there are also factors which make sexual violence more likely in these spaces.

Listen to Podcast